# OnCo record paper-rosella-relacorilant-lancet-2025 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-rosella-relacorilant-lancet-2025/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-rosella-relacorilant-lancet-2025" ;
  schema:name "ROSELLA: relacorilant plus nab-paclitaxel in platinum-resistant ovarian cancer"@en ;
  schema:description "Adding relacorilant, a drug that blocks the cortisol receptor and thereby restores chemotherapy sensitivity, to nab-paclitaxel lengthened progression-free and overall survival in platinum-resistant ovarian cancer regardless of any biomarker."@en ;
  schema:url <https://onco.cc/key-papers/paper-rosella-relacorilant-lancet-2025/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S0140-6736(25)01040-2>, <https://pubmed.ncbi.nlm.nih.gov/40473448/> ;
  schema:sameAs <https://doi.org/10.1016/S0140-6736(25)01040-2> ;
  schema:datePublished "2025"^^xsd:gYear ;
  schema:author "Olawaiye AB, Gladieff L, O'Malley DM, et al." ;
  onco:cancers <https://onco.cc/cancers/platinum-resistant-ovarian-cancer/> ;
  onco:drugs <https://onco.cc/drugs/relacorilant/> ;
  onco:trials <https://onco.cc/trials/rosella/> ;
  onco:journals <https://onco.cc/journals/lancet/> .
